Dr. Els Beirnaert is the current CEO of Aelin Therapeutics in Leuven (Flanders), a biotech startup focused on the discovery and development of breakthrough Pept-in™-based therapeutics.
She offers two decades of experience in drug development, venture and business development. In 2001, she is one of the founders of biopharma company Ablynx – now a Sanofi subsidiary.
She helped start up many life sciences companies, serving as the Head of New Ventures at the Flanders Institute of Biotechnology (VIB) and a board member for biotech firms Confo Therapeutics, Q-Biologicals and Multiplicom.
Flanders’ life sciences industry: the perfect combo of biotech, medtech, pharma and healthcare
Defining Flanders’ life sciences industry as diverse is an understatement. From young start-ups to established local firms and multinationals: the entire value chain – from research and discovery to development and commercialization – is represented in Belgium’s northern region. Thanks to fertile cross-pollination between biotech, medtech, pharmaceuticals and healthcare, Flanders offers a unique life sciences ecosystem that is underpinned by a robust financing landscape and a supportive government. Will your company claim its place in this dynamic hub?